Christian G Huber1, Dieter Naber, Martin Lambert. 1. University Medical Centre Hamburg-Eppendorf, Psychosis Early Detection and Intervention Centre, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, Martinistreet 52, D-20246 Hamburg, Germany. c.huber@uke.uni-hamburg.de
Abstract
BACKGROUND: Up to 50% of first-episode psychosis patients suffer from long-term incomplete remission or treatment resistance. Different definitions for these terms have been used in psychiatric research, making generalized statements about the prevalence and predictors of treatment resistance difficult. OBJECTIVE: The aim of this study was to give an overview on state-of-the-art definitions of treatment resistance for each of the diagnoses making up the inhomogeneous diagnostic entity 'psychosis' and to analyze the factors leading to treatment resistance. METHODS: A computerized and manual literature search for relevant articles published within recent years was undertaken. RESULTS: In addition to symptomatic criteria, patients' functional level and quality of life have to be considered in the definition of treatment resistance. Patient-related, illness-related and treatment-related predictors of treatment resistance and incomplete remission might help to identify subjects at risk and optimize interventions.
BACKGROUND: Up to 50% of first-episode psychosispatients suffer from long-term incomplete remission or treatment resistance. Different definitions for these terms have been used in psychiatric research, making generalized statements about the prevalence and predictors of treatment resistance difficult. OBJECTIVE: The aim of this study was to give an overview on state-of-the-art definitions of treatment resistance for each of the diagnoses making up the inhomogeneous diagnostic entity 'psychosis' and to analyze the factors leading to treatment resistance. METHODS: A computerized and manual literature search for relevant articles published within recent years was undertaken. RESULTS: In addition to symptomatic criteria, patients' functional level and quality of life have to be considered in the definition of treatment resistance. Patient-related, illness-related and treatment-related predictors of treatment resistance and incomplete remission might help to identify subjects at risk and optimize interventions.
Authors: Robert McCutcheon; Katherine Beck; Michael A P Bloomfield; Tiago R Marques; Maria Rogdaki; Oliver D Howes Journal: J Psychopharmacol Date: 2015-03-18 Impact factor: 4.153
Authors: Borja García-Bueno; Miquel Bioque; Karina S MacDowell; Javier Santabárbara; Mónica Martínez-Cengotitabengoa; Carmen Moreno; Pilar A Sáiz; Esther Berrocoso; Patricia Gassó; M Fe Barcones; Ana González-Pinto; Mara Parellada; Julio Bobes; Juan A Micó; Miguel Bernardo; Juan C Leza Journal: Int J Neuropsychopharmacol Date: 2014-10-31 Impact factor: 5.176
Authors: J M Stevenson; J L Reilly; M S H Harris; S R Patel; P J Weiden; K M Prasad; J A Badner; V L Nimgaonkar; M S Keshavan; J A Sweeney; J R Bishop Journal: Transl Psychiatry Date: 2016-02-23 Impact factor: 6.222